Teriparatide is a peptide drug that includes the active component of parathyroid hormone [PTH (1-34)], which is proven to be the first Food and Drug Administration (FDA)-approved anabolic agent to treat osteoporosis. This evidence concerns the gene PTH and osteoporosis.